$2.1 Billion Agreement Accelerates Immunotherapies Targeting Toxic Forms of Amyloid Beta

Retrieved on: 2024-05-13 16:08:57

Tags for this article:

Click the tags to see associated articles and topics

$2.1 Billion Agreement Accelerates Immunotherapies Targeting Toxic Forms of Amyloid Beta. View article details on hiswai:

Excerpt

... Neuroscience Therapeutic Area Unit and Head, Global Development at Takeda, in a press release on May 13, 2024. "Combining AC Immune's deep ...

Article found on: www.precisionvaccinations.com